Cancer and Leukemia Epigenetics and Biology Program, Josep Carreras Leukemia Research Institute, Barcelona, Spain.

Dr. Laura Belver obtained her BSc degrees in Biology (2006) and Biochemistry (2011) from the Autonomous University of Madrid, and completed her PhD in Molecular Biology in 2011 under the supervision of Dr. Almudena Ramiro at the Spanish National Cancer Center – CNIO (Madrid, Spain). Her doctoral work, focused on the role of microRNAs in preventing B-cell-driven autoimmunity, received the IV Biogen-Idec Award for Young Scientist in 2011, alongside the Outstanding Doctoral Thesis Award from the Autonomous University of Madrid.

In 2012, Dr. Belver joined Dr. Adolfo Ferrando’s lab at Columbia University (New York, NY, USA) for postdoctoral training, where her research focused on molecular mechanisms governing enhancer function in T-cell acute lymphoblastic leukemia (T-ALL). Her work highlighted the dominant role of oncogenic enhancer accessibility in leukemia development, and its relevance was broadly recognized in the field.

From 2020, Dr. Belver leads the Leukemia and Immuno-Oncology group at the Josep Carreras Leukemia Research Institute (Barcelona, Spain). Her main research interest is the study of the molecular mechanisms driving leukemia and autoimmunity, and the development of experimental therapies for the treatment of these diseases.